C0282581||B-cell epitopes
C0206255||malaria vaccine
C3849939||P. falciparum Schizont Egress Antigen-1
C0003241||antibodies
C3849939||PfSEA-1A
C0024530||malaria
C0042196||Vaccination
C0025929||mice
C4040232||PbSEA-1A
C0242723||parasitemia
C0032149||Plasmodium berghei ANKA
C4277607||immunogenicity
C3849939||PfSEA-1A
C0282581||B-cell epitopes
C0030956||peptide
C0020960||anti-sera
C3849939||rPfSEA-1A
C1519885||vaccinated
C0033147||primates
C0220825||evaluated
C0003316||epitope
C0003241||antibody
C0242723||parasitemia
C0087111||treatment
C0599755||cohort
C0022558||Western Kenya
C0003241||Antibodies
C0003316||epitopes
C0242723||parasitemia
C0042213||immunogens
C0003261||antibody responses
C0003316||epitopes